Loading organizations...
Gesval serves as the technology transfer and intellectual property management entity for the University of Liège (ULiège) and CHU Liège. It identifies, protects, and valorizes intellectual assets stemming from academic research, effectively bridging scientific discoveries with marketable innovations. The organization facilitates licensing and strategic partnerships, enhancing the economic and societal impact of university intellectual property.
Established on August 26, 1991, Gesval S.A. is a public limited company wholly owned by the University of Liège. Its foundation arose from the foresight to commercialize academic breakthroughs, creating a dedicated structure to professionalize intellectual property management and transfer. This ensures university innovations contribute tangible value and benefit.
Gesval primarily serves industry partners and enterprises seeking advanced technologies and intellectual property from ULiège and CHU Liège. Customers engage to license patents, form collaborative research agreements, or invest in spin-off companies. The company’s vision focuses on accelerating academic discovery to market, ensuring university innovations translate into effective applications and deliver impact.
Gesval has 2 tracked investments across 2 companies. The latest tracked deal is $10.6M Series C in Ampacimon in October 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 17, 2023 | Ampacimon | $10.6M Series C | Pieter JAN Mermans | Creos, Korys, Noshaq |
| Jan 23, 2018 | Cell Matters | $870K Series A | — | Jean Pierre Delwart, Marc Foidart |